Cargando…
Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by...
Autores principales: | Shahzad, Hira, Sheikh, Aisha, Sheikh, Lumaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575245/ https://www.ncbi.nlm.nih.gov/pubmed/23110890 http://dx.doi.org/10.1186/1756-0500-5-606 |
Ejemplares similares
-
Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2017) -
SAT-275 Bitemporal Hemianopia as a Result of Cabergoline Therapy for Macroprolactinoma
por: Díaz-Balzac, Carlos A, et al.
Publicado: (2020) -
A macroprolactinoma becoming resistant to cabergoline and developing
atypical pathology
por: Sbardella, Emilia, et al.
Publicado: (2016) -
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
por: Lee, Youngki, et al.
Publicado: (2014) -
Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline
por: Shibue, Kimitaka, et al.
Publicado: (2022)